Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

1.60 Million Euro for Aging Researcher in Jena – Francesco Neri is awarded Sofja Kovalevskaja Award

16.11.2016

In acknowledgement of his research, junior researcher Francesco Neri from Jena, Germany, was awarded the Sofja Kovalevskaja Award on November 15, 2016, in Berlin. The prize, which is granted by the Alexander von Humboldt Foundation, is one of the most prestigious science awards in Germany and will be used to study the molecular causes of cancer in old age.

Why does the risk of accumulating mutations in cells and developing cancer rise during aging? This is what molecular geneticist Francesco Neri is trying to answer in his studies at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI).


Francesco Neri (center) received the Sofja Kovalevskaja Award on November 15, 2016, in Berlin.

(Source: Humboldt Foundation/David Ausserhofer)

Investigating intestinal stem cells, he is especially interested in the role of DNA methylation – a chemical process by which the DNA of a cell in modified to react on environmental influences. Neri has developed innovative Next Generation Sequencing techniques to identify mechanisms, which are involved into this process and lead to harmful DNA changes instead of useful modifications.

On November 15, 2016, the junior researcher was awarded the Sofja Kovalevskaja Award by the Alexander von Humboldt Foundation, one of the most prestigious science awards in Germany providing 1.60 Million Euro for future research.

Big Chance for a Young Scientist

"I am greatly honored to receive this award“, Francesco Neri happily states. “As an internationally renowned research institute in the area of aging research, the FLI offers me an optimal research environment. The award now enables me to fully concentrate on my own research focus.”

“The Sofja Kovalevskaja Award provides young researchers with a great opportunity to follow their creative research approaches on a nearly independent basis“, Prof. Dr. Karl Lenhard Rudolph, Scientific Director of Leibniz Institute on Aging (FLI), emphasizes the importance of the research award. The funding of the Alexander von Humboldt Foundation enables Francesco Neri to build up a new junior research group on “Epigenetics of Aging“ at the Institute in Jena.

The Laureate – Francesco Neri

Dr. Francesco Neri was born in Italy in 1981. He studied molecular biology and gained his PhD in biotechnology at the University of Siena. He did postdoctoral research at the Human Genetics Foundation in Torino from 2011 to 2016. He was also twice visiting researcher at Radboud University Medical Centre in Nijmegen, Netherlands during this period. He focused his research on the epigenetics of stem cells applying Next Generation Sequencing as a main approach. Since July 2016, Dr. Neri has been heading a junior research group at FLI.

Sofja Kovalevskaja Award for Young Promising Scientists

The Alexander von Humboldt Foundation’s Sofja Kovalevskaja Award is named after the Russian mathematician Sofja Kovalevskaja and is one of the most highly endowed research awards in Germany. Funded by the Federal Ministry of Education and Research, it is granted to young exceptionally promising researchers from abroad in recognition of outstanding academic achievements. The award is designed to enable them to embark on academic careers in Germany by establishing their own junior research groups at research institutions in Germany. The Kovalevskaja Award is endowed with up to 1.65 million Euros. More information on the award can be found on http://www.humboldt-foundation.de/web/start.html.

Contact

Dr. Evelyn Kästner
Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)
Beutenbergstr. 11, 07745 Jena, Germany
Tel.: 03641-656373, Fax: 03641-656351
E-Mail: presse@leibniz-fli.de


Background Information

The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) is the first German research organization dedicated to biomedical aging research since 2004. More than 330 members from over 30 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit http://www.leibniz-fli.de.

The Leibniz Association connects 88 independent research institutions that range in focus from the natural, engineering and environmental sciences via economics, spatial and social sciences to the humanities. Leibniz Institutes address issues of social, economic and ecological relevance. They conduct knowledge-driven and applied basic research, maintain scientific infrastructure and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer to policy-makers, academia, business and the public. Leibniz Institutes collaborate intensively with universities – in the form of “WissenschaftsCampi” (thematic partnerships between university and non-university research institutes), for example – as well as with industry and other partners at home and abroad. They are subject to an independent evaluation procedure that is unparalleled in its transparency. Due to the institutes’ importance for the country as a whole, they are funded jointly by the Federation and the Länder, employing some 18,100 individuals, including 9,200 researchers. The entire budget of all the institutes is approximately 1.64 billion EUR. See http://www.leibniz-association.eu for more information.

Weitere Informationen:

http://www.leibniz-fli.de - Website Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)

Dr. Kerstin Wagner | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>